GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Resverlogix Corp (OTCPK:RVXCF) » Definitions » Cash per Share

RVXCF (Resverlogix) Cash per Share : $0.00 (As of Sep. 2024)


View and export this data going back to 2010. Start your Free Trial

What is Resverlogix Cash per Share?

Cash per Share is calculated as Cash, Cash Equivalents, Marketable Securities divided by Shares Outstanding (EOP). Resverlogix's Cash per Share for the quarter that ended in Sep. 2024 was $0.00.


Resverlogix Cash per Share Historical Data

The historical data trend for Resverlogix's Cash per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Resverlogix Cash per Share Chart

Resverlogix Annual Data
Trend Apr14 Apr15 Apr16 Apr17 Apr18 Apr19 Apr20 Dec21 Dec22 Dec23
Cash per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.04 - - - -

Resverlogix Quarterly Data
Oct19 Jan20 Apr20 Jul20 Oct20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Cash per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Resverlogix Cash per Share Calculation

This is the ratio of a company's available cash, including easy to liquidate short-term investment, to its total number of shares outstanding. The result indicates the percentage of a company's share price that is available to spend on company's activities, such as strengthening the business, paying down the debt and making dividend payment to shareholders. It's a reliable indicator of a company's financial health.

Resverlogix's Cash per Share for the fiscal year that ended in Dec. 2023 is calculated as:

Resverlogix's Cash per Share for the quarter that ended in Sep. 2024 is calculated as:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Resverlogix  (OTCPK:RVXCF) Cash per Share Explanation

Cash per Share represents the liquidity of a compant's assets. A high level of Cash per Share suggests that there's enough money on hand for a company to cover any emergencies and that the company has adequate money to reinvest its business or pay dividends to investors. However, if the ratio is too high, it can also suggeust the inefficiency of management for not making a full usage of the cash.


Resverlogix Cash per Share Related Terms

Thank you for viewing the detailed overview of Resverlogix's Cash per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Resverlogix Business Description

Traded in Other Exchanges
Address
4820 Richard Road South West, Suite 300, Calgary, AB, CAN, T3E 6L1
Resverlogix Corp clinical-stage biotechnology company. The company is developing apabetalone (RVX-208), a first-in-class, small molecule that is a selective BET (bromodomain and extra terminal) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. Apabetalone is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. This selective inhibition of apabetalone on BD2 produces a specific set of biological effects with potentially important benefits for patients with chronic disease including cardiovascular disease (CVD) and associated comorbidities, and COVID-19.

Resverlogix Headlines

From GuruFocus

Resverlogix Corp. - Special Call Transcript

By GuruFocus Research 02-14-2024

Resverlogix Announces Annual and Special Meeting of Shareholders

By GlobeNewswire GlobeNewswire 08-22-2019

Resverlogix Corp Annual Shareholders Meeting Transcript

By GuruFocus Research 02-14-2024

Resverlogix Corp Annual Shareholders Meeting Transcript

By GuruFocus Research 02-14-2024

Resverlogix Corp. - Special Call Transcript

By GuruFocus Research 02-14-2024

Resverlogix Announces One-Year Extension of Debenture

By GlobeNewswire GlobeNewswire 04-19-2022

Resverlogix to Host BETonMACE Webcast and Conference Call

By GlobeNewswire GlobeNewswire 09-27-2019

Resverlogix Corp. - Special Call Transcript

By GuruFocus Research 02-14-2024